NO20026194L - Selektive androgen-reseptor-modulatorer og fremgangsmåter for deres identifikasjon, utforming og anvendelse - Google Patents
Selektive androgen-reseptor-modulatorer og fremgangsmåter for deres identifikasjon, utforming og anvendelseInfo
- Publication number
- NO20026194L NO20026194L NO20026194A NO20026194A NO20026194L NO 20026194 L NO20026194 L NO 20026194L NO 20026194 A NO20026194 A NO 20026194A NO 20026194 A NO20026194 A NO 20026194A NO 20026194 L NO20026194 L NO 20026194L
- Authority
- NO
- Norway
- Prior art keywords
- identification
- design
- methods
- androgen receptor
- receptor modulators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21439200P | 2000-06-28 | 2000-06-28 | |
US23351900P | 2000-09-19 | 2000-09-19 | |
US28473001P | 2001-04-18 | 2001-04-18 | |
US28443801P | 2001-04-18 | 2001-04-18 | |
US28461701P | 2001-04-18 | 2001-04-18 | |
PCT/US2001/019665 WO2002000617A2 (fr) | 2000-06-28 | 2001-06-20 | Modulateurs selectifs des recepteurs androgeniques et leurs methodes d'identification, d'elaboration et d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20026194D0 NO20026194D0 (no) | 2002-12-23 |
NO20026194L true NO20026194L (no) | 2003-02-26 |
Family
ID=27539683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20026194A NO20026194L (no) | 2000-06-28 | 2002-12-23 | Selektive androgen-reseptor-modulatorer og fremgangsmåter for deres identifikasjon, utforming og anvendelse |
Country Status (14)
Country | Link |
---|---|
US (2) | US6960474B2 (fr) |
EP (1) | EP1299094A2 (fr) |
JP (1) | JP2004509072A (fr) |
KR (1) | KR20030016310A (fr) |
CN (1) | CN1454083A (fr) |
AU (2) | AU8821301A (fr) |
BR (1) | BR0111298A (fr) |
CA (1) | CA2413417A1 (fr) |
CZ (1) | CZ20024214A3 (fr) |
HU (1) | HUP0303172A3 (fr) |
IL (1) | IL152719A0 (fr) |
MX (1) | MXPA02012605A (fr) |
NO (1) | NO20026194L (fr) |
WO (1) | WO2002000617A2 (fr) |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071957A (en) | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
US6995284B2 (en) | 2000-08-24 | 2006-02-07 | The University Of Tennessee Research Foundation | Synthesis of selective androgen receptor modulators |
US7001911B2 (en) * | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
US20030114420A1 (en) * | 2000-06-28 | 2003-06-19 | Salvati Mark E. | Fused cyclic modulators of nuclear hormone receptor function |
US20040077605A1 (en) * | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
NZ523802A (en) * | 2000-06-28 | 2005-11-25 | Bristol Myers Squibb Co | Fused cyclic compounds as modulators of nuclear hormone receptor function |
US8008348B2 (en) | 2001-12-06 | 2011-08-30 | University Of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
US6998500B2 (en) | 2000-08-24 | 2006-02-14 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US7855229B2 (en) * | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
US8445534B2 (en) | 2000-08-24 | 2013-05-21 | University Of Tennessee Research Foundation | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs |
US7645898B2 (en) * | 2000-08-24 | 2010-01-12 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and method of use thereof |
US7622503B2 (en) * | 2000-08-24 | 2009-11-24 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US6838484B2 (en) | 2000-08-24 | 2005-01-04 | University Of Tennessee Research Foundation | Formulations comprising selective androgen receptor modulators |
US20070173546A1 (en) * | 2000-08-24 | 2007-07-26 | Dalton James T | Selective androgen receptor modulators and method of use thereof |
US7026500B2 (en) | 2000-08-24 | 2006-04-11 | University Of Tennessee Research Foundation | Halogenated selective androgen receptor modulators and methods of use thereof |
EP1854798A3 (fr) * | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire |
ES2260244T3 (es) * | 2000-09-19 | 2006-11-01 | Bristol-Myers Squibb Company | Compuesto de succinamida heterociclicos condensados y analogos de los mismos, moduladores de la funcion del receptor nuclear de hormona. |
US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US20080249183A1 (en) * | 2001-11-29 | 2008-10-09 | Steiner Mitchell S | Treatment of androgen-deprivation induced osteoporosis |
US20050080143A1 (en) * | 2001-11-29 | 2005-04-14 | Steiner Mitchell S. | Treatment of androgen-deprivation induced osteoporosis |
US20060269611A1 (en) * | 2001-11-29 | 2006-11-30 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
JP4605557B2 (ja) | 2001-12-06 | 2011-01-05 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 選択的アンドロゲンレセプタ修飾因子を用いた筋萎縮治療 |
US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
US8853266B2 (en) | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
ES2310622T3 (es) | 2001-12-19 | 2009-01-16 | Bristol-Myers Squibb Company | Compuestos heterociclicos condensados y analogos de los mismos, moduladores de la funcion de los receptores nucleares de hormonas. |
TWI263640B (en) * | 2001-12-19 | 2006-10-11 | Bristol Myers Squibb Co | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
EA200901492A1 (ru) | 2002-02-07 | 2010-08-30 | Юниверсити Оф Теннесси Рисерч Фаундейшн | Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов (sarm) |
WO2003074450A2 (fr) | 2002-02-28 | 2003-09-12 | The University Of Tennessee Research Corporation | Modulateurs selectifs radiomarques de recepteur d'androgene et leurs utilisations dans l'imagerie et la therapie du cancer de la prostate |
KR20040101251A (ko) | 2002-02-28 | 2004-12-02 | 유니버시티 오브 테네시 리서치 파운데이션 | 다치환된 선택적 안드로겐 수용체 모듈레이터 및 이를사용하는 방법 |
EP1359160A1 (fr) * | 2002-02-28 | 2003-11-05 | Pfizer Products Inc. | Myoblastes squelettiques, qui surexpriment un récepteur androgène |
US7772433B2 (en) * | 2002-02-28 | 2010-08-10 | University Of Tennessee Research Foundation | SARMS and method of use thereof |
US7803970B2 (en) | 2002-02-28 | 2010-09-28 | University Of Tennessee Research Foundation | Multi-substitued selective androgen receptor modulators and methods of use thereof |
GEP20074191B (en) | 2002-06-17 | 2007-09-10 | Univ Tennessee Res Foundation | N-bridged selective androgen receptor modulators and methods of use thereof |
US7741371B2 (en) | 2002-06-17 | 2010-06-22 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
BR0313405A (pt) * | 2002-08-12 | 2005-07-12 | Takeda Pharmaceutical | Compostos, métodos para preparar um composto e para prevenir e/ou tratar câncer, prodroga, medicamento, modulador do receptor de androgênio, agente para prevenir e/ou tratar hipogonadismo ou pertubação climatérica masculina, osteoporose e câncer, e, uso de um composto |
AU2003287075A1 (en) * | 2002-10-15 | 2004-05-04 | Gtx, Inc. | Treating obesity with selective androgen receptor modulators |
US20060276539A1 (en) * | 2002-10-16 | 2006-12-07 | Dalton James T | Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS |
US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US7332525B2 (en) | 2003-01-17 | 2008-02-19 | Castle Erik P | Method of treatment of prostate cancer and composition for treatment thereof |
FR2860793A1 (fr) * | 2003-10-14 | 2005-04-15 | Entomed | Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations |
EP2476415A3 (fr) * | 2003-10-14 | 2012-08-29 | University of Tennessee Research Foundation | Traitement des troubles osseux avec des modulateurs sélectifs de récepteurs d'androgène |
RU2422450C2 (ru) | 2003-11-19 | 2011-06-27 | Метабазис Терапеутикс, Инк. | Новые фосфорсодержащие тиромиметики |
CN1930181A (zh) | 2004-01-07 | 2007-03-14 | 恩多研究公司 | 螺旋12定向的甾族药品 |
US7417040B2 (en) * | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US7378426B2 (en) * | 2004-03-01 | 2008-05-27 | Bristol-Myers Squibb Company | Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
US20110237664A1 (en) * | 2004-06-07 | 2011-09-29 | Dalton James T | Selective androgen receptor modulators for treating diabetes |
US7709516B2 (en) | 2005-06-17 | 2010-05-04 | Endorecherche, Inc. | Helix 12 directed non-steroidal antiandrogens |
WO2007015567A1 (fr) * | 2005-08-01 | 2007-02-08 | Takeda Pharmaceutical Company Limited | Composé d'amine cyclique |
ATE478852T1 (de) * | 2005-09-09 | 2010-09-15 | Schering Corp | Neue 4-cyano-, 4-amino-, und 4- aminomethylderivative von pyrazoloä1,5- aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h- indazolverbindungen und 5-cyano-, 5-amino- und 5- aminomethylderivative von imidazoä1,2-aüpyridinen,und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
EP2039695A4 (fr) | 2006-07-11 | 2010-09-15 | Takeda Pharmaceutical | Composé hétérocyclique bicycique et son utilisation |
US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
PL2054049T3 (pl) | 2006-08-24 | 2016-11-30 | Podstawione acyloanilidy i sposoby ich stosowania | |
US7468439B2 (en) * | 2006-09-06 | 2008-12-23 | Bristol-Myers Squibb Company | Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function |
EP2094643B1 (fr) | 2006-12-01 | 2012-02-29 | Bristol-Myers Squibb Company | Inhibiteurs d'amino cetp étendus |
US20080176255A1 (en) * | 2007-01-23 | 2008-07-24 | Edward Sobek | Mold detection composition and methods |
US9284345B2 (en) | 2007-04-12 | 2016-03-15 | Endorecherche, Inc. | 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
CN101687881A (zh) * | 2007-06-27 | 2010-03-31 | 百时美施贵宝公司 | 可用作核激素受体功能调节剂的稠合杂环化合物 |
US7968603B2 (en) | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
US8466171B2 (en) * | 2007-11-01 | 2013-06-18 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
US8354446B2 (en) | 2007-12-21 | 2013-01-15 | Ligand Pharmaceuticals Incorporated | Selective androgen receptor modulators (SARMs) and uses thereof |
US8268872B2 (en) * | 2008-02-22 | 2012-09-18 | Radius Health, Inc. | Selective androgen receptor modulators |
BRPI0907844B8 (pt) * | 2008-02-22 | 2021-05-25 | Radius Health Inc | compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos |
US20090280112A1 (en) * | 2008-05-05 | 2009-11-12 | The Regents Of The University Of California | Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells |
JP5816087B2 (ja) | 2008-08-29 | 2015-11-18 | エンメエッセディ・イタリア・エッセ・エッレ・エッレ | Smoアンタゴニストとしての飽和二環式複素環誘導体 |
US20120046364A1 (en) | 2009-02-10 | 2012-02-23 | Metabasis Therapeutics, Inc. | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use |
JP5964756B2 (ja) | 2010-02-04 | 2016-08-03 | ラジウス ヘルス,インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
PL2568806T3 (pl) | 2010-05-12 | 2017-03-31 | Radius Health, Inc. | Schematy lecznicze |
US8642632B2 (en) | 2010-07-02 | 2014-02-04 | Radius Health, Inc. | Selective androgen receptor modulators |
WO2012047617A1 (fr) | 2010-09-28 | 2012-04-12 | Radius Health, Inc. | Modulateurs sélectifs du récepteur des androgènes |
CN102875556B (zh) * | 2011-07-12 | 2016-03-30 | 天津药明康德新药开发有限公司 | (4s)-1-取代-2,5-二氮杂双环[2,2,1]庚烷衍生物及制备方法 |
KR102668696B1 (ko) * | 2012-01-12 | 2024-05-29 | 예일 유니버시티 | E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법 |
US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
KR102122941B1 (ko) | 2012-07-13 | 2020-06-15 | 지티엑스, 인코포레이티드 | 선택적 안드로겐 수용체 조절자(sarms)를 이용한 안드로겐 수용체(ar) 양성 유방암의 치료 방법 |
ES2764381T3 (es) * | 2012-07-27 | 2020-06-03 | Aragon Pharmaceuticals Inc | Métodos y composiciones para determinar la resistencia a la terapia de receptor de andrógenos |
JP6153613B2 (ja) | 2012-08-23 | 2017-06-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレート | 乳がん治療を決定する方法 |
US9175291B2 (en) | 2012-10-11 | 2015-11-03 | Isis Pharmaceuticals Inc. | Modulation of androgen receptor expression |
US10011874B2 (en) | 2013-02-25 | 2018-07-03 | Novartis Ag | Androgen receptor mutation |
JP6255038B2 (ja) | 2013-02-26 | 2017-12-27 | トリアクト セラピューティクス,インク. | 癌治療 |
CA2923667A1 (fr) | 2013-09-09 | 2015-03-12 | Triact Therapeutics, Inc. | Traitement du cancer |
US9682960B2 (en) | 2013-12-19 | 2017-06-20 | Endorecherche, Inc. | Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety |
WO2015108988A2 (fr) | 2014-01-17 | 2015-07-23 | Ligand Pharmaceuticals, Inc. | Méthodes et compositions pour moduler les taux d'hormone |
CN105640645A (zh) * | 2014-11-26 | 2016-06-08 | 华东医院 | 一种多囊卵巢动物模型的建立方法及其应用 |
EP3247708A4 (fr) * | 2015-01-20 | 2018-09-12 | Arvinas, Inc. | Composés et procédés pour la dégradation ciblée du récepteur des androgènes |
US20170327469A1 (en) | 2015-01-20 | 2017-11-16 | Arvinas, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
PL3474841T3 (pl) | 2016-06-22 | 2022-07-11 | Ellipses Pharma Ltd | Sposoby leczenia nowotworu złośliwego piersi ar+ |
RS64208B1 (sr) | 2016-10-11 | 2023-06-30 | Arvinas Operations Inc | Jedinjenja i metode za ciljanu degradaciju androgenog receptora |
US11220515B2 (en) | 2018-01-26 | 2022-01-11 | Yale University | Imide-based modulators of proteolysis and associated methods of use |
BR112022012110A2 (pt) | 2019-12-19 | 2022-12-13 | Arvinas Operations Inc | Compostos e métodos para a degradação direcionada de receptor androgênico |
CN112064141B (zh) * | 2020-08-17 | 2022-11-25 | 咖法科技(上海)有限公司 | 一种含茶叶渣的聚乳酸纤维面料制作方法及其面料 |
US11701332B2 (en) * | 2020-11-18 | 2023-07-18 | Bryce Nicholas Day | Methods and compositions for treating female sexual interest and arousal disorder |
Family Cites Families (114)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3343940A (en) | 1964-06-12 | 1967-09-26 | Pennsalt Chemicals Corp | Process for plant desiccation |
US3261845A (en) | 1964-07-14 | 1966-07-19 | Dow Chemical Co | N-phenyl derivatives of 3,6-epoxyhexahydrophthalimide |
US3428538A (en) | 1966-01-13 | 1969-02-18 | Peter Scheiner | Method for preparing aziridines by photolysis of triazolines |
JPS4916937B1 (fr) * | 1970-01-21 | 1974-04-25 | ||
US4089650A (en) | 1971-12-20 | 1978-05-16 | Petrolite Corporation | Use of Diels-Alder adducts of dihydro-nitrogen heterocyclic phosphoramidates as corrosion inhibitors |
US3998833A (en) | 1971-12-20 | 1976-12-21 | Petrolite Corporation | Diels-alder adducts of dihydro-nitrogen heterocyclic phosphoramidates |
US3923490A (en) | 1971-12-20 | 1975-12-02 | Petrolite Corp | Use of 1,2-dihydro-pyridine-N-phosphonates and thiophosphonates as microbiocides |
US3965264A (en) | 1971-12-20 | 1976-06-22 | Petrolite Corporation | Process for controlling microbiological organisms in aqueous or petroleum hydrocarbon systems |
US3821232A (en) | 1971-12-20 | 1974-06-28 | Petrolite Corp | 1,2-dihydro-pyridine-n-phosphonates and thiophosphonates |
JPS5032306B2 (fr) | 1972-11-02 | 1975-10-20 | ||
US3925554A (en) | 1972-11-30 | 1975-12-09 | Sumitomo Chemical Co | Certain 3,5-dichlorophenyl compound used as a plant fungicide |
US3948933A (en) | 1973-11-01 | 1976-04-06 | Gruppo Lepetit S.P.A. | Pyrrolo[1,2-c]imidazolediones |
NL7501563A (nl) | 1974-02-28 | 1975-09-01 | Merck & Co Inc | Werkwijze voor het bereiden van preparaten te- gen het samenpakken van bloedplaatjes. |
US3997293A (en) | 1974-03-19 | 1976-12-14 | Petrolite Corporation | Use of dihydro-nitrogen heterocyclic phosphoramidates as corrosion inhibitors |
JPS5417047Y2 (fr) * | 1974-06-24 | 1979-07-03 | ||
FR2329276A1 (fr) | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
JPS5188631A (en) * | 1975-01-31 | 1976-08-03 | Hiiryoyosatsukinzai oyobi sonoseizoho | |
DE2862100D1 (en) | 1977-10-12 | 1983-01-05 | Ici Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
MC1220A1 (fr) * | 1977-10-28 | 1979-07-20 | Hoffmann La Roche | Nouveaux derives d'imidazolidine |
IL55774A (en) | 1977-10-28 | 1982-04-30 | Sparamedica Ag | Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture |
US4191775A (en) | 1977-12-15 | 1980-03-04 | Imperial Chemical Industries Limited | Amide derivatives |
DE2817157A1 (de) | 1978-04-17 | 1979-10-25 | Schering Ag | Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie |
FR2465486A1 (fr) | 1979-09-21 | 1981-03-27 | Roussel Uclaf | Nouvelle application utilisant la lh-rh ou des agonistes |
FR2492381A1 (fr) | 1980-10-21 | 1982-04-23 | Science Union & Cie | Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
DE3121152A1 (de) | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie" |
US4753957A (en) | 1981-09-28 | 1988-06-28 | Rohm And Haas Company | Substituted 2,4-imidazolidinediones and fungicidal compositions |
US5210213A (en) | 1983-06-17 | 1993-05-11 | The Boeing Company | Dimensional, crosslinkable oligomers |
US4536559A (en) | 1983-06-17 | 1985-08-20 | The Boeing Company | Thermally stable polyimide polysulfone compositions for composite structures |
US5104967A (en) | 1987-09-03 | 1992-04-14 | The Boeing Company | Amideimide oligomers and blends |
US5155206A (en) | 1987-09-03 | 1992-10-13 | The Boeing Company | Crosslinkable polyamideimide oligomers and a method of preparation |
US4584364A (en) | 1984-02-06 | 1986-04-22 | The Boeing Company | Phenolic-capped imide sulfone resins |
US5693741A (en) | 1988-03-15 | 1997-12-02 | The Boeing Company | Liquid molding compounds |
US5516876A (en) | 1983-09-27 | 1996-05-14 | The Boeing Company | Polyimide oligomers and blends |
US5645925A (en) | 1988-03-14 | 1997-07-08 | Boeing Company | Advanced composite blends |
US5512676A (en) | 1987-09-03 | 1996-04-30 | The Boeing Company | Extended amideimide hub for multidimensional oligomers |
US5116935A (en) | 1987-05-04 | 1992-05-26 | The Boeing Company | Polyimide oligomers and blends and method of curing |
US5286811A (en) | 1983-09-27 | 1994-02-15 | The Boeing Company | Blended polyimide oligomers and method of curing polyimides |
US5367083A (en) | 1987-09-03 | 1994-11-22 | The Boeing Company | Extended acid halide capping monomers |
US5780583A (en) | 1991-01-09 | 1998-07-14 | The Boeing Company | Reactive polyarylene sulfide oligomers |
US4851495A (en) | 1987-02-20 | 1989-07-25 | The Boeing Company | Polyetherimide oligomer |
US5446120A (en) | 1985-10-07 | 1995-08-29 | The Boeing Company | Polyethersulfone oligomers and blends |
US5714566A (en) | 1981-11-13 | 1998-02-03 | The Boeing Company | Method for making multiple chemically functional oligomers |
US4507303A (en) | 1981-12-22 | 1985-03-26 | Sumitomo Chemical Company, Limited | Succinimide derivatives, compositions and method of use |
DE3382406D1 (de) * | 1982-04-08 | 1991-10-17 | Shell Int Research | Neue hydantoine, ihre herstellung und verwendung. |
DE3227055A1 (de) * | 1982-07-20 | 1984-01-26 | Hoechst Ag, 6230 Frankfurt | Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung |
US4473393A (en) | 1982-08-06 | 1984-09-25 | Buffalo Color Corporation | Pesticidal thiohydantoin compositions |
US4980481A (en) | 1983-06-17 | 1990-12-25 | The Boeing Company | End-cap monomers and oligomers |
US5112939A (en) | 1983-06-17 | 1992-05-12 | The Boeing Company | Oligomers having pyrimidinyl end caps |
US4739030A (en) | 1983-06-17 | 1988-04-19 | The Boeing Company | Difunctional end-cap monomers |
US4476184A (en) | 1983-08-09 | 1984-10-09 | The Boeing Company | Thermally stable polysulfone compositions for composite structures |
US4582886A (en) | 1984-02-27 | 1986-04-15 | General Electric Company | Heat curable epoxy resin compositions and epoxy resin curing agents |
US4562255A (en) | 1984-03-30 | 1985-12-31 | American Home Products Corporation | Substituted bi-alicyclic imides |
US4533737A (en) | 1984-04-02 | 1985-08-06 | General Electric Company | Silicon functionalized norbornane carboxyimide and methods for making |
GB8411928D0 (en) | 1984-05-10 | 1984-06-13 | Robinson Bros Ltd | Preparing substituted oxazolines |
US4760053A (en) | 1984-08-02 | 1988-07-26 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
US4659695A (en) | 1985-02-08 | 1987-04-21 | Fernand Labrie | Method of treatment of prostate cancer |
US4775660A (en) | 1984-08-02 | 1988-10-04 | Fernand Labrie | Treatment of breast cancer by combination therapy |
US4666885A (en) | 1985-02-08 | 1987-05-19 | Fernand Labrie | Combination therapy for treatment of female breast cancer |
US4670536A (en) | 1985-06-01 | 1987-06-02 | Director-General Of Agency Of Industrial Science And Technology | Addition-curable quinoxaline resin oligomer and intermediate material for fiber-reinforced composite |
US4656235A (en) | 1985-09-05 | 1987-04-07 | Polytechnic Institute Of New York | Siloxane-containing polyimide coatings for electronic devices |
US5594089A (en) | 1985-09-05 | 1997-01-14 | The Boeing Company | Heterocycle or heterocycle sulfone oligomers with multiple chemically functional end caps |
US5151487A (en) | 1985-09-30 | 1992-09-29 | The Boeing Company | Method of preparing a crosslinking oligomer |
US5084472A (en) | 1986-11-04 | 1992-01-28 | Roussel | Application of 1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4'-dimethylimidazoline 2,5-dione in the treatment of hormone-dependent cancers other than that of the prostate |
FR2619381B1 (fr) | 1987-08-13 | 1989-12-08 | Roussel Uclaf | Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation |
US4892578A (en) | 1987-11-06 | 1990-01-09 | Fmc Corporation | Phenylmethyl-4,4-dimethyl-3-isoxazolidinone plant regulators |
US5817744A (en) | 1988-03-14 | 1998-10-06 | The Boeing Company | Phenylethynyl capped imides |
US4895715A (en) | 1988-04-14 | 1990-01-23 | Schering Corporation | Method of treating gynecomastia |
US5750373A (en) * | 1990-12-03 | 1998-05-12 | Genentech, Inc. | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
DE69022722T2 (de) | 1989-03-10 | 1996-05-02 | Endorecherche Inc., Ste-Foy, Quebec | Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen. |
US5595985A (en) | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
FR2649110B1 (fr) | 1989-06-29 | 1994-10-21 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP3332377B2 (ja) | 1989-07-07 | 2002-10-07 | アンドルシェルシュ・インコーポレイテッド | 良性前立腺過形成の予防および/または治療のための組合せ療法 |
FR2656302B1 (fr) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveau procede de preparation de l'anandron et derives de l'anandron. |
US5114612A (en) | 1990-04-04 | 1992-05-19 | The United States Of America As Represented By The Department Of Energy | Liquid crystal polyester thermosets |
JP2800953B2 (ja) | 1990-07-06 | 1998-09-21 | 住友製薬株式会社 | 新規なイミド誘導体 |
US5093500A (en) | 1990-10-17 | 1992-03-03 | Shell Oil Company | Spirodilactam bisimides |
HUT62296A (en) | 1990-12-18 | 1993-04-28 | Sandoz Ag | Herbicidal composition comprising hydantoin derivative as active ingredient and process for producing the active ingredient |
FR2671348B1 (fr) * | 1991-01-09 | 1993-03-26 | Roussel Uclaf | Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
USRE35956E (en) | 1991-01-09 | 1998-11-10 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
US5411981A (en) | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
ZA924811B (en) | 1991-06-28 | 1993-12-29 | Endorecherche Inc | Controlled release systems and low dose androgens |
CA2131528C (fr) * | 1992-03-05 | 2004-07-13 | Philip E. Thorpe | Agents diagnostiques et/ou therapeutiques cibles pour les cellules endotheliales neovasculaires |
FR2694290B1 (fr) | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
JPH08501537A (ja) | 1992-09-10 | 1996-02-20 | デグッサ アクチエンゲゼルシャフト | 除草剤としての二環式イミド |
JPH06235309A (ja) * | 1992-12-16 | 1994-08-23 | Mitsubishi Motors Corp | 内燃機関用動弁装置 |
IL107719A0 (en) | 1992-12-21 | 1994-02-27 | Du Pont | Imidazolones their manufacture and their use as herbicides |
US5399725A (en) | 1993-05-27 | 1995-03-21 | Bristol-Myers Squibb Co. | 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same |
US5514571A (en) | 1993-08-05 | 1996-05-07 | University Technologies International Inc. | Cyclin D1 negative regulatory activity |
TW521073B (en) | 1994-01-05 | 2003-02-21 | Hoechst Marion Roussel Inc | New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them |
FR2716110B1 (fr) | 1994-02-16 | 1996-04-05 | Roussel Uclaf | Compositions cosmétiques ou pharmaceutiques comprenant des liposomes. |
GB2295088B (en) | 1994-09-14 | 1998-11-25 | Univ Sheffield | Control of hair growth |
EP0873361B1 (fr) * | 1995-12-13 | 2006-11-02 | The Regents Of The University Of California | Cristaux du domaine de liaison de ligands du récepteur d'hormone thyroïde complexé à un ligand |
FR2742749B1 (fr) * | 1995-12-22 | 1998-02-06 | Roussel Uclaf | Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques |
US6017924A (en) * | 1996-06-27 | 2000-01-25 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
DE19643555A1 (de) * | 1996-10-24 | 1998-04-30 | Univ Dresden Tech | Metallischer Gegenstand mit einer dünnen mehrphasigen Oxidschicht sowie Verfahren zu dessen Herstellung |
US6071957A (en) | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
US5929146A (en) | 1996-12-27 | 1999-07-27 | Minnesota Mining And Manufacturing Company | Modifying agents for polyolefins |
US6054487A (en) | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
WO1999010003A1 (fr) * | 1997-08-28 | 1999-03-04 | Janus Pharmaceuticals, Inc. | Antagonistes de l'activite androgene utilises pour le traitement de l'anorexie, de l'anorexie mentale et de troubles caracterises par une insuffisance ponderale pathologique |
US5986055A (en) | 1997-11-13 | 1999-11-16 | Curagen Corporation | CDK2 interactions |
JP2000169474A (ja) | 1998-12-07 | 2000-06-20 | Kotobuki Seiyaku Kk | イソキヌクリジン誘導体及びその製造方法並びにこれを含有する高コレステロール血症治療剤 |
US6184249B1 (en) * | 1998-12-18 | 2001-02-06 | Biophysica, Inc. | Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
US6075053A (en) | 1999-02-09 | 2000-06-13 | Bionumerik Pharmaceuticals, Inc. | Method of reducing or reversing neuropathy |
US6358947B1 (en) * | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
EP1212322A2 (fr) * | 1999-08-27 | 2002-06-12 | Ligand Pharmaceuticals Incorporated | Composes de 6-trifluoromethyl-9-pyrido[3,2-g]quinoline 8-substitues utilises comme modulateurs de recepteurs androgenes |
HUP0202814A3 (en) * | 1999-08-27 | 2003-11-28 | Ligand Pharmaceuticals Inc San | Androgen receptor modulator compounds and methods for their preparation and pharmaceutical compositions containing them and their use |
AU6985300A (en) * | 1999-09-10 | 2001-04-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
IL148192A0 (en) * | 1999-10-14 | 2002-09-12 | Bristol Myers Squibb Co | Crystals of androgen receptor ligand binding domain and methods utilizing the coordinates of the crystal structure |
US6200573B1 (en) * | 1999-12-03 | 2001-03-13 | Starcor Pharmaceuticals, Inc. | Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
CA2408486A1 (fr) * | 2000-05-11 | 2001-11-15 | Bristol-Myers Squibb Company | Analogues de tetrahydroisoquinoline servant de secretagogues d'hormones de croissance |
NZ523802A (en) * | 2000-06-28 | 2005-11-25 | Bristol Myers Squibb Co | Fused cyclic compounds as modulators of nuclear hormone receptor function |
ES2260244T3 (es) * | 2000-09-19 | 2006-11-01 | Bristol-Myers Squibb Company | Compuesto de succinamida heterociclicos condensados y analogos de los mismos, moduladores de la funcion del receptor nuclear de hormona. |
WO2002096426A1 (fr) * | 2001-05-25 | 2002-12-05 | Bristol-Myers Squibb Company | Derives d'hydantoine utilises comme inhibiteurs des metalloproteinases matricielles |
-
2001
- 2001-06-20 EP EP01967933A patent/EP1299094A2/fr not_active Withdrawn
- 2001-06-20 CA CA002413417A patent/CA2413417A1/fr not_active Abandoned
- 2001-06-20 US US09/885,827 patent/US6960474B2/en not_active Expired - Lifetime
- 2001-06-20 JP JP2002505365A patent/JP2004509072A/ja active Pending
- 2001-06-20 BR BR0111298-8A patent/BR0111298A/pt not_active IP Right Cessation
- 2001-06-20 KR KR1020027017856A patent/KR20030016310A/ko not_active Application Discontinuation
- 2001-06-20 CZ CZ20024214A patent/CZ20024214A3/cs unknown
- 2001-06-20 WO PCT/US2001/019665 patent/WO2002000617A2/fr not_active Application Discontinuation
- 2001-06-20 AU AU8821301A patent/AU8821301A/xx active Pending
- 2001-06-20 AU AU2001288213A patent/AU2001288213B2/en not_active Ceased
- 2001-06-20 CN CN01812037A patent/CN1454083A/zh active Pending
- 2001-06-20 MX MXPA02012605A patent/MXPA02012605A/es unknown
- 2001-06-20 IL IL15271901A patent/IL152719A0/xx unknown
- 2001-06-20 HU HU0303172A patent/HUP0303172A3/hu unknown
-
2002
- 2002-12-23 NO NO20026194A patent/NO20026194L/no not_active Application Discontinuation
-
2005
- 2005-05-17 US US11/130,935 patent/US20050256048A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP0303172A2 (hu) | 2003-12-29 |
WO2002000617A2 (fr) | 2002-01-03 |
NO20026194D0 (no) | 2002-12-23 |
US6960474B2 (en) | 2005-11-01 |
WO2002000617A3 (fr) | 2003-01-30 |
AU8821301A (en) | 2002-01-08 |
IL152719A0 (en) | 2003-06-24 |
US20050256048A1 (en) | 2005-11-17 |
CN1454083A (zh) | 2003-11-05 |
US20020173445A1 (en) | 2002-11-21 |
EP1299094A2 (fr) | 2003-04-09 |
MXPA02012605A (es) | 2003-05-14 |
AU2001288213B2 (en) | 2005-04-14 |
JP2004509072A (ja) | 2004-03-25 |
CA2413417A1 (fr) | 2002-01-03 |
CZ20024214A3 (cs) | 2003-04-16 |
KR20030016310A (ko) | 2003-02-26 |
BR0111298A (pt) | 2005-05-10 |
HUP0303172A3 (en) | 2006-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20026194L (no) | Selektive androgen-reseptor-modulatorer og fremgangsmåter for deres identifikasjon, utforming og anvendelse | |
NO20021449L (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse | |
DK1455785T3 (da) | Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse | |
NO20023300D0 (no) | Autentiseringssystem, autentiseringsanordning og terminal | |
NO20030111D0 (no) | Kjemokinreseptor-modulatorer, deres fremstilling og anvendelse | |
DE60139045D1 (de) | Kommunikationsvorrichtung und Kommunikationsverfahren | |
NO20015113L (no) | Nye forbindelser, deres fremstilling og anvendelse | |
NO20055135D0 (no) | Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer | |
NO20030439L (no) | Sikker programmerbar logisk enhet | |
NO20015156L (no) | 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse | |
DK2474694T3 (da) | Sikkerhedsindretning og frigivelsesindretning | |
DE60320785D1 (de) | Kommunikationsverfahren, kommunikationssystem und kommunikationseinrichtung | |
DE60333751D1 (de) | Kommunikationsverfahren, kommunikationssystem und kommunikationseinrichtung | |
DE60126852D1 (de) | Datenkommunikationssystem und Empfangsvorrichtung | |
NO20014603D0 (no) | Tienopyrimidinforbindelser, deres fremstilling og anvendelse | |
NO20025357D0 (no) | Antranylamider og deres anvendelse som legemidler | |
NO20034364L (no) | Sapogenin-derivater, deres syntese og anvendelse samt metoder basert pa deres anvendelse | |
NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
DE60044947D1 (de) | Codemultiplex-kommunikationssystem und codemultiplex-kommunikationsgerät | |
DE60139736D1 (de) | Kommunikationsverfahren und Gerät | |
DE60118450D1 (de) | Kommunikationsverfahren und Kommunikationsgerät | |
DK1261625T3 (da) | Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse | |
NO20025209L (no) | Cyklipostiner, deres fremstilling og anvendelse | |
NO20024107L (no) | Tienopyridin derivater, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |